Holen Sie sich die Stockscreener-App
3.96
0.25%
-0.01
Handel nachbörslich:
4.10
0.14
+3.54%
Schlusskurs vom Vortag:
$3.97
Offen:
$4.02
24-Stunden-Volumen:
278.15K
Relative Volume:
0.44
Marktkapitalisierung:
$272.64M
Einnahmen:
$113.02M
Nettoeinkommen (Verlust:
$-75.07M
KGV:
-3.7978
EPS:
-1.0427
Netto-Cashflow:
$-47.88M
1W Leistung:
+2.86%
1M Leistung:
-11.21%
6M Leistung:
+45.05%
1J Leistung:
+17.86%
1-Tages-Spanne:
$3.93
$4.12
1-Wochen-Bereich:
$3.705
$4.12
52-Wochen-Spanne:
$2.08
$4.58
Orasure Technologies Inc Stock (OSUR) Company Profile
Firmenname
Orasure Technologies Inc
Sektor
Telefon
(503) 641-6115
Adresse
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
3.96 | 273.33M | 113.02M | -75.07M | -47.88M | -1.0427 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-03 | Fortgesetzt | Evercore ISI | In-line |
| 2021-09-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Eingeleitet | Evercore ISI | Outperform |
| 2020-08-10 | Eingeleitet | Citigroup | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
| 2020-08-07 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Eingeleitet | Lake Street | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Equal-Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Mkt Perform |
| 2018-07-16 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Herabstufung | Jefferies | Buy → Hold |
| 2017-02-09 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Bestätigt | Mizuho | Buy |
| 2015-05-07 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Bestätigt | Mizuho | Buy |
| 2014-06-12 | Bestätigt | Canaccord Genuity | Buy |
| 2014-06-11 | Bestätigt | Mizuho | Buy |
| 2012-12-21 | Eingeleitet | Mizuho | Buy |
| 2012-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Orasure Technologies Inc Aktie (OSUR) Neueste Nachrichten
OraSure Technologies Inc (OSUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OSUR|OraSure Technologies Inc|Price:3.800| - TradingKey
OSUR|OraSure Technologies Inc|Price:3.970|Chg%:-0.060 - TradingKey
OraSure Technologies Inc (OSUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OraSure Technologies Inc (OSUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OraSure Technologies, Inc. Revenue Breakdown – LSX:881351 - TradingView
OraSure Technologies, Inc. Revenue Breakdown – TRADEGATE:EP3 - TradingView
3 Promising Penny Stocks With Market Caps Over $60M - simplywall.st
OraSure Technologies Inc (OSUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
OraSure to announce Q2 2026 financial results on August 5 - scanx.trade
OraSure Technologies, Inc. (OSUR) stock price, news, quote and history - Yahoo Finance Singapore
OraSure's Q2 results webcast is set for Aug. 5 after market close - Stock Titan
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th - Moomoo
Bethlehem’s OraSure gets FDA emergency authorization for Ebola test - Lehigh Valley Business
OraSure wins FDA emergency nod for Ebola test (OSUR:NASDAQ) - Seeking Alpha
OraSure receives Emergency Use Authorization for second generation Ebola test - WFMZ.com
AT&T, Cal-Maine Foods, OraSure Technologies - TradingView
Why Has OraSure Technologies (NASDAQ:OSUR) Entered Nasdaq News? - Kalkine Media
OraSure (OSUR) Secures FDA Approval for Enhanced Ebola Rapid Tes - GuruFocus
OraSure Technologies Gets Emergency Use Authorization From FDA for New Ebola Test - marketscreener.com
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test - The Manila Times
Enterprise value to revenue forward of OraSure Technologies, Inc. – MUN:EP3 - TradingView
OraSure Technologies (OSUR) Dips Below $3.90 as Selling Pressure MountsThematic ETF Flow - dars.gov.et
OraSure Technologies (OSUR) Slides 6.8% as Shares Test Critical Support Near $3.76Single Stock ETF - dars.gov.et
OraSure Technologies (OSUR) Slides 6.8% as Key Support Level Comes into FocusAI Trade Signals - dars.gov.et
Bethlehem's OraSure puts another property up for sale - WFMZ.com
OraSure Technologies stock holds steady as diagnostics business targets growth - AD HOC NEWS
OraSure Technologies updates highlight diagnostics focus amid shifting health trends - ad-hoc-news.de
OSUR Q1 2026 Earnings: Significant Earnings Miss as Losses WidenSaaS Earnings Trends - DonanımHaber
OSUROrasure Technologies Inc Latest SEC Filings - Finviz
Form 4 OraSure Technologies Inc For: 30 June By Investing.com - Investing.com Nigeria
OraSure Technologies (OSUR) director takes 3,666-share stock grant in lieu of cash - Stock Titan
Enterprise value to EBIT forward of OraSure Technologies, Inc. – MUN:EP3 - TradingView
Price to earnings forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to book forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to book forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Price to sales forward of OraSure Technologies, Inc. – NASDAQ:OSUR - TradingView
Price to sales forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Enterprise value to revenue forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Price to earnings forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
Enterprise value to EBITDA forward of OraSure Technologies, Inc. – LSX:881351 - TradingView
OraSure Technologies Q1 2026 Earnings: EPS Misses Estimates as Stock Declines Over 4.9%Quarterly Earnings - DonanımHaber
OraSure gets FDA nod for at-home STI urine collection kit - Investing.com Nigeria
3 Promising Penny Stocks With At Least $200M Market Cap - simplywall.st
OraSure Technologies Hits New 52-Week High of $4.36, Marking Significant Growth - MarketsMojo
OraSure Technologies Inc (OSUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OraSure Technologies Inc (OSUR) Institutional Confidence - TradingKey
OraSure Technologies Inc (OSUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
OraSure Technologies Inc (OSUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OraSure Technologies Inc (OSUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Finanzdaten der Orasure Technologies Inc-Aktie (OSUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):